The estimated Net Worth of Alan Charles Foster is at least $24.2 Tysiąc dollars as of 25 March 2022. Dr Foster owns over 4,386 units of Otonomy Inc stock worth over $13,630 and over the last 3 years he sold OTIC stock worth over $10,526.
Sign up
Dr D OTIC stock SEC Form 4 insiders trading
Dr has made over 1 trades of the Otonomy Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he sold 4,386 units of OTIC stock worth $10,526 on 25 March 2022.
The largest trade he's ever made was selling 4,386 units of Otonomy Inc stock on 25 March 2022 worth over $10,526. On average, Dr trades about 2,193 units every 0 days since 2022. As of 25 March 2022 he still owns at least 177,017 units of Otonomy Inc stock.
You can see the complete history of Dr Foster stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Alan Charles Foster Ph.D. biography
Dr. Alan Charles Foster Ph.D. is the Chief Scientific Officer at Otonomy Inc.
How old is Dr D?
Dr D is 65, he's been the Chief Scientific Officer of Otonomy Inc since . There are 1 older and 11 younger executives at Otonomy Inc. The oldest executive at Otonomy Inc is James Breitmeyer, 66, who is the Independent Director.
What's Dr D's mailing address?
Alan's mailing address filed with the SEC is C/O OTONOMY, INC., 4796 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121.
Insiders trading at Otonomy Inc
Over the last 10 years, insiders at Otonomy Inc have traded over $30,282,796 worth of Otonomy Inc stock and bought 755,065 units worth $12,114,945 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Holdings A/S Novo oraz Brian H Dovey. On average, Otonomy Inc executives and independent directors trade stock every 66 days with the average trade being worth of $7,317. The most recent stock trade was executed by Vickie L Capps on 28 November 2022, trading 42,242 units of OTIC stock currently worth $4,224.
What does Otonomy Inc do?
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
What does Otonomy Inc's logo look like?
Complete history of Dr Foster stock trades at Otonomy Inc
Otonomy Inc executives and stock owners
Otonomy Inc executives and other stock owners filed with the SEC include:
-
David Weber,
President, Chief Executive Officer, Director -
Dr. David Allen Weber,
Pres, CEO & Director -
Paul Cayer,
Chief Financial and Business Officer -
Robert Savel,
Chief Technical Officer -
Paul E. Cayer,
Chief Financial & Bus. Officer -
Robert Michael Savel II,
Chief Technical Officer -
Jay Lichter,
Independent Chairman of the Board -
Vickie Capps,
Independent Director -
Iain McGill,
Independent Director -
James Breitmeyer,
Independent Director -
Theodore Schroeder,
Independent Director -
Dr. Jay B. Lichter Ph.D.,
Co-Founder & Independent Chairman -
Ciara Kennedy,
Independent Director -
James Branch CPA,
VP of Fin. & Controller -
David Skarinsky,
Sr. VP of Clinical -
Breianna Bowen,
VP of HR -
Fabrice Piu Ph.D.,
Sr. VP of Preclinical Devel. -
Barbara M. Finn,
Sr. VP of Regulatory Affairs & Quality Assurance -
Dr. Alan Charles Foster Ph.D.,
Chief Scientific Officer -
Julie D. Burgess,
VP of Fin. & Admin. -
Dr. Rick Adam Friedman M.D., Ph.D.,
Co-Founder and Member of the Advisory Panel -
Dr. Allen F. Ryan Ph.D.,
Co-Founder and Member of the Advisory Panel -
Katherine Mary Bishop,
Chief Scientific Officer -
Eric J Loumeau,
GC & Chief Compliance Officer -
Carl Le Bel,
Chief Scientific Officer -
Heather Preston,
Director -
George J Morrow,
Director -
Advisors Llc Orbi Med Capit...,
-
Chau Quang Khuong,
Director -
Anthony J Yost,
Chief Commercial Officer -
Dean Hakanson,
Chief Medical Officer -
John P Mckearn,
Director -
Partners Viii, L.P.Blair Ja...,
-
Ventures Viii Lp Avalon Ven...,
-
Holdings A/S Novo,
10% owner -
Group Holdings (Sbs) Adviso...,
-
Viii Associates, L.P.Domain...,
-
Alan Charles Foster,
Chief Scientific Officer -
Brian H Dovey,
Director -
Jill Marie Broadfoot,
Director